February 4, 2019 – Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
January 28, 2019 — Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 21, 2019 — Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force ...
December 18, 2018 — Irish medical device company AuriGen Medical won the prestigious Global Innovation Award at the ...
November 30, 2018 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate ...
November 7, 2018 — Here is a list of some of the key clinical trial presentations at the 2018 American Heart Association ...
October 9, 2018 — Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the ...
August 28, 2018 — Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
July 13, 2018 — Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a ...
July 5, 2018 — Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in ...
June 27, 2018 — Results from a 902-person, five-country survey of people living with atrial fibrillation (AF) reinforce ...